Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sarepta Therapeutics
Pharma
Roche to launch another Elevidys study, eying EU approval
Following feedback from the EMA and the Duchenne community, Roche plans to generate additional placebo-controlled data required for a resubmission.
Angus Liu
Apr 16, 2026 10:06am
Sarepta CEO to retire, citing 'shocking and ironic twist of fate'
Feb 26, 2026 11:30am
Sarepta to test Elevidys with immunosuppressive regimen
Nov 25, 2025 2:19pm
FDA limits Elevidys gene therapy to ambulatory Duchenne patients
Nov 14, 2025 3:20pm
Catalent cuts 77 more jobs in Maryland
Nov 10, 2025 4:18pm
Sarepta, despite key trial flop, will seek full nod for DMD meds
Nov 4, 2025 7:56am
